##  [Novartis receives FDA approval for Cosentyx® label update to include moderate to severe scalp psoriasis](/us-en/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis-0 "Novartis receives FDA approval for Cosentyx® label update to include moderate to severe scalp psoriasis") 

  Feb 08, 2018